Recent Finacing
Recent Raise
Carolus Therapeutics develops drugs that noninvasively monitor and modulate pro-inflammatory chemokine interactions to prevent or reverse inflammation, focusing clinical and commercialization efforts on respiratory diseases like cystic fibrosis.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor